Literature DB >> 17117078

FDG PET/CT flip flop phenomenon in treated lymphoma of bone.

Eugene C Lin1.   

Abstract

A 47-year-old man with primary large B-cell lymphoma of bone underwent an F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) scan for staging. The study demonstrated multiple areas of uptake consistent with osseous lymphoma. After multiple cycles of chemotherapy, a follow-up study demonstrated a dramatic flip flop appearance in which the previously noted areas of osseous lymphoma were photopenic and normal marrow appeared to have increased activity. This flip flop appearance could incorrectly suggest lymphomatous infiltration of normal marrow.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17117078     DOI: 10.1097/01.rlu.0000246858.03018.0c

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  4 in total

1.  Time-dependent changes in 18F-FDG activity in the thymus and bone marrow following combination chemotherapy in paediatric patients with lymphoma.

Authors:  Ingeborg Goethals; Pieter Hoste; Ciel De Vriendt; Peter Smeets; Joris Verlooy; Hamphrey Ham
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10-10       Impact factor: 9.236

2.  Heterogeneous bone marrow uptake on interim 18F-fluorodeoxyglucose positron emission tomography for lymphoma mimicking disease progression: a case report.

Authors:  Martin H Cherk; Sushrut Patil; Paul Beech; Victor Kalff
Journal:  J Med Case Rep       Date:  2014-11-07

3.  Heterogeneous Marrow Uptake on FDG PET/CT is not Always a Sign of Lymphomatous Involvement.

Authors:  Arun Kumar Reddy Gorla; Bhagwant Rai Mittal; Anish Bhattacharya; Pankaj Malhotra; Subhash Varma
Journal:  World J Nucl Med       Date:  2016 Jan-Apr

4.  A Pitfall for Diffusion-weighted MR Imaging When Assessing the Response to Neoadjuvant Chemotherapy in Ewing Sarcoma.

Authors:  Ömer Kasalak; Albert J H Suurmeijer; Jacco J De Haan; Hugo J A Adams; Paul C Jutte; Thomas C Kwee
Journal:  Magn Reson Med Sci       Date:  2018-12-06       Impact factor: 2.471

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.